CD274 and hepatocellular carcinoma: HCC patients with HBV preS2 deletion in the circulation display a higher number of regulatory T cells (Tregs) and a higher expression level of immune checkpoint molecule programmed death ligand 1 (PD-L1) in tumor tissues than do patients without preS2 deletion [28,29].